{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:38:52Z","timestamp":1794886732959,"version":"4.9.1"},"update-to":[{"DOI":"10.1016\/j.biopha.2024.116211","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000}}],"reference-count":277,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.biopha.2024.116211","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T12:57:06Z","timestamp":1706533026000},"page":"116211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":250,"special_numbering":"C","title":["RETRACTED: A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies"],"prefix":"10.1016","volume":"171","author":[{"given":"Suman","family":"Adhikari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyatosh","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alakesh","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabajyoti","family":"Baildya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim K.","family":"Duttaroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajit","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116211_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mpmed.2007.10.003","article-title":"Principles of cytotoxic chemotherapy","volume":"36","author":"Lind","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2024.116211_bib2","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2174\/1568026622666220516105049","article-title":"A concise review on the role of natural and synthetically derived peptides in colorectal cancer","volume":"22","author":"Das","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib3","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1007\/s12094-023-03200-x","article-title":"A concise review on miRNAs as regulators of colon cancer stem cells and associated signalling pathways","volume":"25","author":"Banerjee","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.biopha.2024.116211_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gutjnl-2022-328233","article-title":"Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time","volume":"72","author":"Li","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2024.116211_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s10989-023-10572-9","article-title":"BMAP-27 peptide reduces proliferation and increases apoptosis in primary and metastatic colon cancer cell lines","volume":"29","author":"Das","year":"2023","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.biopha.2024.116211_bib6","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.7150\/jca.24577","article-title":"Current status and future directions of cancer immunotherapy","volume":"9","author":"Zhang","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2024.116211_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1570163812666150602144310","article-title":"Targeted cancer therapy: the next generation of cancer treatment","volume":"12","author":"Baudino","year":"2015","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.biopha.2024.116211_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155913","article-title":"Immunotherapeutic potential of ethanolic olive leaves extract (EOLE) and IL-28B combination therapy in ENU induced animal model of leukemia","volume":"156","author":"Nath","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2024.116211_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcp.24791","article-title":"Gene therapies for cancer: strategies, challenges and successes","volume":"230","author":"Das","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2024.116211_bib10","first-page":"250","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.biopha.2024.116211_bib11","series-title":"Handb. Oxidative Stress Cancer Ther. Asp.","first-page":"3877","article-title":"A General Overview on Causes, Risk Factors, Diagnosis, Treatment, and Role of Oxidative Stress Biomarkers in Colorectal Cancer","author":"Sriramulu","year":"2022"},{"key":"10.1016\/j.biopha.2024.116211_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s10989-023-10503-8","article-title":"An updated review on recent advances in the usage of novel therapeutic peptides for breast cancer treatment","volume":"29","author":"Das","year":"2023","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.biopha.2024.116211_bib13","first-page":"685","article-title":"An updated review on the role of nanoformulated phytochemicals in colorectal cancer","volume":"59","author":"Das","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2024.116211_bib14","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.18632\/oncotarget.12673","article-title":"Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assays","volume":"8","author":"Eastman","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.116211_bib15","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1021\/cr900208x","article-title":"Introduction to cancer chemotherapeutics","volume":"109","author":"Shewach","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2023.110646","article-title":"Antiproliferative evaluation and supramolecular properties of a Pd(II) complex harvested from benzil bis(pyridyl hydrazone) ligand: combined experimental and theoretical studies","volume":"152","author":"Adhikari","year":"2023","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.biopha.2024.116211_bib17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.drudis.2009.09.003","article-title":"Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs","volume":"14","author":"van Rijt","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2024.116211_bib18","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1039\/c3cc41143e","article-title":"Exploration of the medical periodic table: towards new targets","volume":"49","author":"Barry","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biopha.2024.116211_bib19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1039\/b514859f","article-title":"Design of targeting ligands in medicinal inorganic chemistry","volume":"35","author":"Storr","year":"2006","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib20","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1515\/pac-2014-0504","article-title":"100 years of metal coordination chemistry: from Alfred Werner to anticancer metallodrugs","volume":"86","author":"Barry","year":"2014","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cbpa.2007.11.013","article-title":"New trends for metal complexes with anticancer activity","volume":"12","author":"Bruijnincx","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.biopha.2024.116211_bib22","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1021\/acs.jmedchem.7b01694","article-title":"Organometallic Gold(III) Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress-Mediated Apoptosis and Pro-Death Autophagy in A549 Cancer Cells","volume":"61","author":"Huang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/jm100020w","article-title":"Organometallic anticancer compounds","volume":"54","author":"Gasser","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1039\/B707077M","article-title":"Bioorganometallic chemistry\u2014from teaching paradigms to medicinal applications","volume":"38","author":"Hartinger","year":"2009","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib25","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1039\/b411910j","article-title":"Deoxyribozymes: DNA catalysts for bioorganic chemistry","volume":"2","author":"Silverman","year":"2004","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib26","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/cr400460s","article-title":"Metallodrugs in medicinal inorganic chemistry","volume":"114","author":"Mjos","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib27","series-title":"Medicinal Inorganic Chemistry","year":"2005"},{"key":"10.1016\/j.biopha.2024.116211_bib28","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1021\/cr900134a","article-title":"Application of metal coordination chemistry to explore and manipulate cell biology","volume":"109","author":"Haas","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"222","author":"ROSENBERG","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116211_bib30","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2174\/0929867054637626","article-title":"Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches","volume":"12","author":"Galanski","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2147\/DDDT.S119488","article-title":"Metal complexes in cancer therapy \u2013 an update from drug design perspective","volume":"Volume11","author":"Ndagi","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.biopha.2024.116211_bib32","series-title":"Handb. Anim. Model. Its Uses Cancer Res.","first-page":"1","article-title":"Recent Advances of Metal-Based Anticancer Agents and Their In Vivo Potential Against Various Types of Malignancies","author":"Nath","year":"2022"},{"key":"10.1016\/j.biopha.2024.116211_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2022.121157","article-title":"Exploring dithiolate-amine binary ligand systems for the supramolecular assemblies of Ni(II) coordination compounds: Crystal structures, theoretical studies, cytotoxicity studies, and molecular docking studies","volume":"543","author":"Bhattacharjee","year":"2022","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.biopha.2024.116211_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.116211_bib35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/pharmaceutics14040743","article-title":"Current advances of nanomedicines delivering arsenic trioxide for enhanced tumor therapy","volume":"14","author":"Yu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.116211_bib36","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2174\/1567201815666180727145724","article-title":"Anti-lung cancer and anti-angiogenic activities of new designed boronated phenylalanine metal complexes","volume":"15","author":"Varol","year":"2018","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.biopha.2024.116211_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2013.11.004","article-title":"Molecularly targeted cancer therapy: some lessons from the past decade","volume":"35","author":"Huang","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib38","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1021\/jm701264d","article-title":"Synthesis and structure\u2013activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide","volume":"51","author":"Payen","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112234","article-title":"Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity","volume":"193","author":"Bian","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/BF00133563","article-title":"Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties","volume":"10","author":"Sava","year":"1992","journal-title":"Clin. Exp. Metastas-.-."},{"key":"10.1016\/j.biopha.2024.116211_bib41","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.3390\/ijms22147568","article-title":"Ruthenium(II) and platinum(II) complexes with biologically active aminoflavone ligands exhibit in vitro anticancer activity","volume":"22","author":"Fabija\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib42","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/acsmedchemlett.9b00098","article-title":"High in vitro and in vivo tumor-selective novel ruthenium(II) complexes with 3-(2\u2032-Benzimidazolyl)-7-fluoro-coumarin","volume":"10","author":"Qin","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2024.116211_bib43","doi-asserted-by":"crossref","unstructured":"B.K. Keppler, M. Henn, U.M. Juhl, M.R. Berger, R. Niebl, F.E. Wagner, New Ruthenium Complexes for the Treatment of Cancer, in: 1989: pp. 41\u201369. \u3008https:\/\/doi.org\/10.1007\/978\u20133-642\u201374760-1_3\u3009.","DOI":"10.1007\/978-3-642-74760-1_3"},{"key":"10.1016\/j.biopha.2024.116211_bib44","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1016\/j.ejca.2013.05.018","article-title":"The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo","volume":"49","author":"Heffeter","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2024.116211_bib45","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.2147\/DDDT.S275007","article-title":"Ruthenium complexes as anticancer agents: a brief history and perspectives","volume":"Volume 14","author":"Lee","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.biopha.2024.116211_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-010-1293-1","article-title":"Ruthenium-based chemotherapeutics: are they ready for prime time?","volume":"66","author":"Antonarakis","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/187152009787313837","article-title":"Copper complexes as anticancer agents","volume":"9","author":"Marzano","year":"2009","journal-title":"Anticancer. Agents Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ccr.2014.08.002","article-title":"Noble metals in medicine: latest advances","volume":"284","author":"Medici","year":"2015","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib49","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1039\/C8DT01858H","article-title":"Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium","volume":"47","author":"Konkankit","year":"2018","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib50","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode","volume":"205","author":"ROSENBERG","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116211_bib51","first-page":"1799","article-title":"The successful regression of large solid sarcoma 180 tumors by platinum compounds","volume":"30","author":"Rosenberg","year":"1970","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2024.116211_bib52","first-page":"325","article-title":"Inhibition of Dunning asc itic leukemia and Walker 256 carcinosarcoma with cis-diamminedichloroplatinum (NSC-119875)","volume":"54","author":"Kociba","year":"1970","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.biopha.2024.116211_bib53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/pr.111.005637","article-title":"Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes","volume":"64","author":"Shen","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib54","first-page":"471","article-title":"Understanding and improving platinum anticancer drugs--phenanthriplatin","volume":"34","author":"Johnstone","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.biopha.2024.116211_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157489206775246458","article-title":"Platinum complexes as anticancer agents","volume":"1","author":"Kostova","year":"2006","journal-title":"Recent Pat. Anticancer. Drug Discov."},{"key":"10.1016\/j.biopha.2024.116211_bib57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1595\/147106710X534326","article-title":"Michele peyrone (1813-1883), discoverer of cisplatin","volume":"54","author":"Kauffman","year":"2010","journal-title":"Platin. Met. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib58","series-title":"Cisplatin","first-page":"193","article-title":"Antitumor, toxic and biochemical properties of cisplatin and eight other platinum complexes","author":"Harrap","year":"1980"},{"key":"10.1016\/j.biopha.2024.116211_bib59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0162-0134(00)80069-0","article-title":"The structure of the antitumor complex cis-(diammino) (1,1-cyclobutanedicarboxylato)-Pt(II): X ray and nmr studies","volume":"13","author":"Neidle","year":"1980","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib60","doi-asserted-by":"crossref","unstructured":"M.A. Jakupec, M.S. Galanski, B.K. Keppler, Tumour-inhibiting platinum complexes\u2014state of the art and future perspectives, in: 2003: pp. 1\u201353. \u3008https:\/\/doi.org\/10.1007\/s10254\u2013002-0001-x\u3009.","DOI":"10.1007\/s10254-002-0001-x"},{"key":"10.1016\/j.biopha.2024.116211_bib61","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0026-895X(24)12463-7","article-title":"Oxaliplatin-induced damage of cellular DNA","volume":"58","author":"Woynarowski","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib62","doi-asserted-by":"crossref","DOI":"10.1053\/sonc.2002.35524","article-title":"Oxaliplatin-related side effects: characteristics and management","volume":"29","author":"Cassidy","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.biopha.2024.116211_bib63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/CMAR.S35785","article-title":"Nedaplatin: a cisplatin derivative in cancer chemotherapy","author":"Shimada","year":"2013","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.biopha.2024.116211_bib64","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1248\/bpb.28.1385","article-title":"Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation","volume":"28","author":"Kawai","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2024.116211_bib65","first-page":"2349","article-title":"Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function","volume":"5","author":"Welink","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2024.116211_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-2952(95)00085-E","article-title":"Induction of the c-myc but not the cH-ras promoter by platinum compounds","volume":"50","author":"Eliopoulos","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib67","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.3390\/ijms21134618","article-title":"An overview of coumarin as a versatile and readily accessible scaffold with broad-ranging biological activities","volume":"21","author":"Annunziata","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2018.10.035","article-title":"Quinoline and quinolone dimers and their biological activities: an overview","volume":"161","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113555","article-title":"Quinoline anticancer agents active on DNA and DNA-interacting proteins: from classical to emerging therapeutic targets","volume":"220","author":"Lauria","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib70","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1021\/acs.jmedchem.5b00444","article-title":"Water-soluble ruthenium(II) complexes with chiral 4-(2,3-Dihydroxypropyl)-formamide oxoaporphine (FOA): in vitro and in vivo anticancer activity by stabilization of G-quadruplex DNA, inhibition of telomerase activity, and induction of tumor cell apoptosis","volume":"58","author":"Chen","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111751","article-title":"Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives","volume":"184","author":"Qin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib72","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00280-019-03773-x","article-title":"In vitro and in vivo anticancer effects of two quinoline\u2013platinum(II) complexes on human osteosarcoma models","volume":"83","author":"Ruiz","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.783127","article-title":"Jatrorrhizine: a review of sources, pharmacology, pharmacokinetics and toxicity","volume":"12","author":"Zhong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111727","article-title":"High in vitro and in vivo antitumor activities of luminecent platinum(II) complexes with jatrorrhizine derivatives","volume":"183","author":"Qin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib75","doi-asserted-by":"crossref","first-page":"16128","DOI":"10.1021\/acs.inorgchem.1c01763","article-title":"Antitumor activities for two Pt(II) complexes of tropolone and 8-hydroxyquinoline derivative","volume":"60","author":"Mo","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib76","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1039\/C5DT03831F","article-title":"Targeting of DNA molecules, BSA\/c-Met tyrosine kinase receptors and anti-proliferative activity of bis(terpyridine)copper( <scp>ii<\/scp>) complexes","volume":"45","author":"Mahendiran","year":"2016","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib77","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00775-017-1488-6","article-title":"In vitro and in vivo anti-proliferative evaluation of bis(4\u2032-(4-tolyl)-2,2\u2032:6\u2032,2\u2033-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors","volume":"22","author":"Mahendiran","year":"2017","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2019.03.014","article-title":"In vitro and in vivo antitumor activities of three novel binuclear platinum(II) complexes with 4\u2032-substituted-2,2\u2032:6\u2032,2\u2033-terpyridine ligands","volume":"170","author":"Qin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib79","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1039\/C8DT01946K","article-title":"Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum( <scp>ii<\/scp>) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum( <scp>ii<\/scp>) complexes in relation to the compl","volume":"47","author":"Konovalov","year":"2018","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib80","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00775-020-01770-7","article-title":"New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities","volume":"25","author":"Franich","year":"2020","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib81","doi-asserted-by":"crossref","first-page":"348","DOI":"10.20892\/j.issn.2095-3941.2017.0033","article-title":"Cell cycle regulation and anticancer drug discovery","volume":"14","author":"Jingwen","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.biopha.2024.116211_bib82","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.cdd.4402257","article-title":"R-Roscovitine simultaneously targets both the p53 and NF-\u03baB pathways and causes potentiation of apoptosis: implications in cancer therapy","volume":"15","author":"Dey","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2024.116211_bib83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00775-019-01735-5","article-title":"Platinum(II)-oxalato complexes of seliciclib (CYC202) derivatives show different cellular effects and lesser adverse effects in mouse lymphoma model than cisplatin","volume":"25","author":"Van\u010do","year":"2020","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112033","article-title":"Design, synthesis and biological evaluation of naphthalenebenzimidizole platinum (II) complexes as potential antitumor agents","volume":"188","author":"Liang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib85","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00210-022-02302-7","article-title":"Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight","volume":"396","author":"Tudu","year":"2023","journal-title":"Naunyn. Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib86","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/molecules21121758","article-title":"Cryptolepine, a plant alkaloid, inhibits the growth of non-melanoma skin cancer cells through inhibition of topoisomerase and induction of DNA damage","volume":"21","author":"Pal","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116211_bib87","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00044-021-02739-0","article-title":"Strong in vitro and in vivo cytotoxic effects of two platinum(II) complexes with cryptolepine derivatives","volume":"30","author":"Qin","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.biopha.2024.116211_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112109","article-title":"Ferrocene-containing hybrids as potential anticancer agents: current developments, mechanisms of action and structure-activity relationships","volume":"190","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41570-017-0066","article-title":"The medicinal chemistry of ferrocene and its derivatives","volume":"1","author":"Patra","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202201259","article-title":"A rationally designed bimetallic platinum (ii)\u2010ferrocene antitumor agent induces non\u2010apoptotic cell death and exerts in vivo efficacy","volume":"28","author":"Gadre","year":"2022","journal-title":"Chem. \u2013 A Eur. J."},{"key":"10.1016\/j.biopha.2024.116211_bib91","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfac054","article-title":"In vitro and in vivo antitumor studies of potential anticancer agents of platinum(II) complexes of dicyclopentadiene and dithiocarbamates","volume":"14","author":"Sulaiman","year":"2022","journal-title":"Metallomics"},{"key":"10.1016\/j.biopha.2024.116211_bib92","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3390\/pharmaceutics14102013","article-title":"In vitro and in vivo relevant antineoplastic activity of platinum(II) complexes toward triple-negative MDA-MB-231 breast cancer cell line","volume":"14","author":"Maciel","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.116211_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.111773","article-title":"Platinum(II) complexes with malonic acids: synthesis, characterization, in vitro and in vivo antitumor activity and interactions with biomolecules","volume":"231","author":"Dimitrijevi\u0107 Stojanovi\u0107","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112144","article-title":"In-vitro cytotoxicity and in-vivo antitumor activity of two platinum complexes with 1,3-dimethyl pentyl glycine ligand against breast cancer","volume":"241","author":"Bazsefidpar","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib95","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/17425247.2022.2134341","article-title":"Current trends in the use of human serum albumin for drug delivery in cancer","volume":"19","author":"Paul","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2024.116211_bib96","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1021\/acs.jmedchem.3c00001","article-title":"Developing an anticancer platinum(II) compound based on the uniqueness of human serum albumin","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib97","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1002\/ange.201904131","article-title":"An Antitumor Bis(N\u2010Heterocyclic Carbene)Platinum(II) Complex That Engages Asparagine Synthetase as an Anticancer Target","volume":"131","author":"Hu","year":"2019","journal-title":"Angew. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib98","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/ejic.201601278","article-title":"Platinum(IV) prodrugs \u2013 a step closer to Ehrlich\u2019s vision?","volume":"2017","author":"Kenny","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib99","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/mp200597r","article-title":"Conjugate of Pt(IV)\u2013histone deacetylase inhibitor as a prodrug for cancer chemotherapy","volume":"9","author":"Yang","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2024.116211_bib100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jinorgbio.2013.09.003","article-title":"Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells","volume":"129","author":"Alessio","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib101","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-03864-w","article-title":"Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates","volume":"7","author":"Novohradsky","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116211_bib102","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00775-017-1459-y","article-title":"In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells","volume":"22","author":"Arsenijevic","year":"2017","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib103","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1039\/C5SC04205D","article-title":"Pt( <scp>iv<\/scp>) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action","volume":"7","author":"Raveendran","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib104","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1039\/C6MT00226A","article-title":"Comparative studies of oxaliplatin-based platinum( <scp>iv<\/scp>) complexes in different in vitro and in vivo tumor models","volume":"9","author":"G\u00f6schl","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.biopha.2024.116211_bib105","doi-asserted-by":"crossref","first-page":"19070","DOI":"10.1002\/anie.202008604","article-title":"PlatinER: a highly potent anticancer platinum(II) complex that induces endoplasmic reticulum stress driven immunogenic cell death","volume":"59","author":"Tham","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biopha.2024.116211_bib106","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1039\/C7DT01054K","article-title":"Synthesis, characterization and in vitro and in vivo anticancer activity of Pt( <scp>iv<\/scp>) derivatives of [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)]","volume":"46","author":"Harper","year":"2017","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib107","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1039\/D0DT00424C","article-title":"Naproxen platinum( <scp>iv<\/scp>) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo","volume":"49","author":"Chen","year":"2020","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib108","doi-asserted-by":"crossref","first-page":"23313","DOI":"10.1002\/anie.202011273","article-title":"Multispecific platinum(IV) complex deters breast cancer via interposing inflammation and immunosuppression as an inhibitor of COX\u20102 and PD\u2010L1","volume":"59","author":"Jin","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.116211_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105677","article-title":"Recent developments on 1,8-Naphthalimide moiety as potential target for anticancer agents","volume":"121","author":"Tandon","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126670","article-title":"A potent aminonaphthalimide platinum(IV) complex with effective antitumor activities in vitro and in vivo displaying dual DNA damage effects on tumor cells","volume":"29","author":"Wang","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2024.116211_bib111","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejmech.2019.02.063","article-title":"Multifunctional platinum(IV) complexes as immunostimulatory agents to promote cancer immunochemotherapy by inhibiting tryptophan-2,3-dioxygenase","volume":"169","author":"Hua","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.592654","article-title":"Pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence","volume":"11","author":"Salehi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104430","article-title":"Platinum(IV) complexes conjugated with chalcone analogs as dual targeting anticancer agents: In vitro and in vivo studies","volume":"105","author":"Huang","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib114","doi-asserted-by":"crossref","first-page":"13070","DOI":"10.1039\/C6DT00763E","article-title":"Encapsulation of lipophilic kiteplatin Pt( <scp>iv<\/scp>) prodrugs in PLGA-PEG micelles","volume":"45","author":"Margiotta","year":"2016","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jinorgbio.2015.11.028","article-title":"Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands","volume":"160","author":"Margiotta","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib116","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.3390\/ijms23137081","article-title":"Improvement of kiteplatin efficacy by a benzoato Pt(IV) prodrug suitable for oral administration","volume":"23","author":"Barbanente","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0003-9861(02)00218-7","article-title":"The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase\/extracellular signal-regulated kinase signaling pathway","volume":"403","author":"Sanna","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2024.116211_bib118","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00432-004-0617-0","article-title":"Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells","volume":"131","author":"Kapitza","year":"2005","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.116211_bib119","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.3033","article-title":"NKP-1339: maximum tolerated dose defined for first-in-human GRP78 targeted agent","volume":"30","author":"Thompson","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.116211_bib120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/acs.chemrev.8b00211","article-title":"Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433","volume":"119","author":"Monro","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib121","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/inorganics7030031","article-title":"Designing ruthenium anticancer drugs: what have we learnt from the key drug candidates?","volume":"7","author":"Coverdale","year":"2019","journal-title":"Inorganics"},{"key":"10.1016\/j.biopha.2024.116211_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202201645","article-title":"Ruthenium complexes as potential cancer cell growth inhibitors for targeted chemotherapy","volume":"7","author":"Katheria","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.biopha.2024.116211_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01323","article-title":"Applications of ruthenium complex in tumor diagnosis and therapy","volume":"9","author":"Lin","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib124","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.molliq.2018.01.140","article-title":"Synthesis and characterization of ruthenium(III) complex containing 2-aminomethyl benzimidazole, and its anticancer activity of in vitro and in vivo models","volume":"255","author":"Sahyon","year":"2018","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.biopha.2024.116211_bib125","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/j.matpr.2022.07.098","article-title":"Recent advances and application of ruthenium complexes in tumor malignancy","volume":"72","author":"Kanaoujiya","year":"2023","journal-title":"Mater. Today Proc."},{"key":"10.1016\/j.biopha.2024.116211_bib126","doi-asserted-by":"crossref","first-page":"12825","DOI":"10.1002\/slct.201902451","article-title":"Pyridine\u2010based macrocyclic and open receptors for urea","volume":"4","author":"Adhikari","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.biopha.2024.116211_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2019.119098","article-title":"Synthesis and characterization of mixed-ligand Zn(II) and Cu(II) complexes including polyamines and dicyano-dithiolate(2-): In vitro cytotoxic activity of Cu(II) compounds","volume":"498","author":"Adhikari","year":"2019","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.biopha.2024.116211_bib128","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jhet.4355","article-title":"Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets","volume":"59","author":"Satija","year":"2022","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/molecules28010040","article-title":"Synthesis, characterization and biological investigations of half-sandwich ruthenium(II) complexes containing benzimidazole moiety","volume":"28","author":"Rogala","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116211_bib130","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.3390\/molecules25184284","article-title":"Ruthenium(II)\/(III) DMSO-based complexes of 2-aminophenyl benzimidazole with in vitro and in vivo anticancer activity","volume":"25","author":"Elsayed","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116211_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102124","article-title":"The potentials of carbon monoxide-releasing molecules in cancer treatment: an outlook from ROS biology and medicine","volume":"46","author":"Tien Vo","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2024.116211_bib132","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1039\/C6DT04295C","article-title":"Ru(CO) x}-Core complexes with benzimidazole ligands: synthesis, X-ray structure and evaluation of anticancer activity in vivo","volume":"46","author":"Tamasi","year":"2017","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib133","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1039\/C9DT00866G","article-title":"Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium( ii)\u2013arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol","volume":"48","author":"Meng","year":"2019","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112763","article-title":"Potent half-sandwich Ru(\u2161) N^N (aryl-BIAN) complexes: lysosome-mediated apoptosis, in vitro and in vivo anticancer activities","volume":"207","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib135","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1002\/chem.202004954","article-title":"Tunable anticancer activity of furoylthiourea\u2010based ru ii \u2013arene complexes and their mechanism of action","volume":"27","author":"Swaminathan","year":"2021","journal-title":"Chem. \u2013 A Eur. J."},{"key":"10.1016\/j.biopha.2024.116211_bib136","doi-asserted-by":"crossref","first-page":"10921","DOI":"10.1021\/ja800194a","article-title":"DNA structural distortions induced by ruthenium\u2212arene anticancer compounds","volume":"130","author":"Gossens","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2024.116211_bib137","doi-asserted-by":"crossref","first-page":"16311","DOI":"10.1039\/D1DT02611A","article-title":"Impact of aliphatic acyl and aromatic thioamide substituents on the anticancer activity of Ru( <scp>ii<\/scp>)- p -cymene complexes with acylthiourea ligands\u2014 in vitro and in vivo studies","volume":"50","author":"Swaminathan","year":"2021","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib138","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1021\/ic5005215","article-title":"New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives","volume":"53","author":"Rilak","year":"2014","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib139","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.arabjc.2016.07.021","article-title":"Highly water-soluble ruthenium(II) terpyridine coordination compounds form stable adducts with blood-borne metal transporting proteins","volume":"11","author":"Ni\u0161avi\u0107","year":"2018","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib140","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1039\/C5DT04132E","article-title":"DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium( <scp>ii<\/scp>) terpyridine complexes","volume":"45","author":"Lazi\u0107","year":"2016","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib141","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.3390\/molecules25204699","article-title":"Antitumor activity of ruthenium(II) terpyridine complexes towards colon cancer cells in vitro and in vivo","volume":"25","author":"Savic","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116211_bib142","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1039\/c3cc00177f","article-title":"The path for metal complexes to a DNA target","volume":"49","author":"Komor","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biopha.2024.116211_bib143","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1021\/jm5005946","article-title":"Luminescent ruthenium complexes for theranostic applications","volume":"57","author":"Cardoso","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111339","article-title":"Enantiomeric selectivity of ruthenium (II) chiral complexes with antitumor activity, in vitro and in vivo","volume":"216","author":"Zhang","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib145","doi-asserted-by":"crossref","first-page":"16353","DOI":"10.1021\/acs.jmedchem.2c01174","article-title":"Potent Ruthenium\u2013Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to In Vivo Evaluation in Zebrafish","volume":"65","author":"M","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115541","article-title":"Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes","volume":"257","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib147","doi-asserted-by":"crossref","first-page":"15686","DOI":"10.1039\/D2DT01659A","article-title":"One pot three component synthesis of DNA targeting phototoxic Ru( <scp>ii<\/scp>)- p -cymene dipyrido[3,2- a:2\u2032,3\u2032- c]phenazine analogues","volume":"51","author":"Kar","year":"2022","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib148","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1021\/acs.inorgchem.3c00570","article-title":"Coordination of Ru(II)-Arene Fragments to Dipyridophenazine Ligands Leads to the Modulation of Their In Vitro and In Vivo Anticancer Activity","volume":"62","author":"Nikoli\u0107","year":"2023","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib149","doi-asserted-by":"crossref","first-page":"22639","DOI":"10.1073\/pnas.2007285117","article-title":"Gold-based therapy: From past to present","volume":"117","author":"Balfourier","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib150","first-page":"32","article-title":"Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models","volume":"45","author":"Mirabelli","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2024.116211_bib151","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1039\/D1CS00933H","article-title":"Recent development of gold( <scp>i<\/scp>) and gold( <scp>iii<\/scp>) complexes as therapeutic agents for cancer diseases","volume":"51","author":"Lu","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib152","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3390\/cancers12082021","article-title":"Gold nanoparticles as a potent radiosensitizer: a transdisciplinary approach from physics to patient","volume":"12","author":"Penninckx","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.116211_bib153","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.bioconjchem.7b00756","article-title":"Synthesis and evaluation of doxorubicin-loaded gold nanoparticles for tumor-targeted drug delivery","volume":"29","author":"Du","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib154","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/nano10091851","article-title":"Synchrotron characterization of hexagonal and cubic lipidic phases loaded with azolate\/phosphane gold(I) compounds: a new approach to the uploading of gold(I)-based drugs","volume":"10","author":"Astolfi","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2024.116211_bib155","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ejmech.2018.06.002","article-title":"In vitro and in vivo studies of gold(I) azolate\/phosphane complexes for the treatment of basal like breast cancer","volume":"155","author":"Gambini","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib156","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejmech.2015.11.003","article-title":"Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives","volume":"107","author":"Xu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib157","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.poly.2009.06.007","article-title":"Comparative studies on the cytotoxicity, cellular and nuclear uptake of a series of chloro gold(I) phosphine complexes","volume":"29","author":"Scheffler","year":"2010","journal-title":"Polyhedron"},{"key":"10.1016\/j.biopha.2024.116211_bib158","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1021\/acs.inorgchem.9b00281","article-title":"Synthesis of Gold(I) Complexes Containing Cinnamide: In Vitro Evaluation of Anticancer Activity in 2D and 3D Spheroidal Models of Melanoma and In Vivo Angiogenesis","volume":"58","author":"Ganga Reddy","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib159","doi-asserted-by":"crossref","unstructured":"I. Ott, Metal N-heterocyclic carbene complexes in medicinal chemistry, in: 2020: pp. 121\u2013148. \u3008https:\/\/doi.org\/10.1016\/bs.adioch.2019.10.008\u3009.","DOI":"10.1016\/bs.adioch.2019.10.008"},{"key":"10.1016\/j.biopha.2024.116211_bib160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ccr.2016.09.004","article-title":"Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs","volume":"329","author":"Liu","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib161","doi-asserted-by":"crossref","first-page":"9197","DOI":"10.1021\/acs.jmedchem.0c00257","article-title":"Halo and Pseudohalo Gold(I)\u2013NHC Complexes Derived from 4,5-Diarylimidazoles with Excellent In Vitro and In Vivo Anticancer Activities Against HCC","volume":"63","author":"Bian","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib162","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/CAD.0000000000000930","article-title":"In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe2 and NHC*-Au-S-GLUC against advanced prostate cancer PC3","volume":"31","author":"Walther","year":"2020","journal-title":"Anticancer. Drugs"},{"key":"10.1016\/j.biopha.2024.116211_bib163","doi-asserted-by":"crossref","first-page":"17130","DOI":"10.1002\/anie.202008046","article-title":"124 I Radiolabeling of a Au III \u2010NHC Complex for In Vivo Biodistribution Studies","volume":"59","author":"Guarra","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.116211_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113893","article-title":"In situ activation of therapeutics through bioorthogonal catalysis","volume":"176","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib165","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1002\/anie.202013366","article-title":"Bioorthogonal activation of dual catalytic and anti\u2010cancer activities of organogold(I) Complexes in living systems","volume":"60","author":"Long","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.116211_bib166","doi-asserted-by":"crossref","first-page":"96062","DOI":"10.18632\/oncotarget.21708","article-title":"Selection and characterization of a human ovarian cancer cell line resistant to auranofin","volume":"8","author":"Landini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.116211_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2017.06.010","article-title":"Anti-cancer gold(I) phosphine complexes: cyclic trimers and tetramers containing the P-Au-P moiety","volume":"175","author":"Reddy","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101310","article-title":"Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma","volume":"28","author":"Sze","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2024.116211_bib169","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3831\/KPI.201.22.007","article-title":"Role of pentacyclic triterpenoids in chemoprevention and anticancer treatment: an overview on targets and underling mechanisms","volume":"22","author":"Ghante","year":"2019","journal-title":"J. Pharmacopunct."},{"key":"10.1016\/j.biopha.2024.116211_bib170","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1002\/chem.202000045","article-title":"A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti\u2010Ovarian\u2010Cancer Agent by Inhibiting TrxR and Activating ROS\u2010Mediated ERS","volume":"26","author":"Bian","year":"2020","journal-title":"Chem. \u2013 A Eur. J."},{"key":"10.1016\/j.biopha.2024.116211_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133717","article-title":"Syntheses, crystal structures, theoretical studies, and anticancer properties of an unsymmetrical schiff base ligand N-2-(6-methylpyridyl)-2-hydroxy-1-naphthaldimine and its Ni(II) complex","volume":"1269","author":"Bhattacharjee","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.biopha.2024.116211_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2019.111655","article-title":"Gold(III) complex from pyrimidine and morpholine analogue Schiff base ligand: Synthesis, characterization, DFT, TDDFT, catalytic, anticancer, molecular modeling with DNA and BSA and DNA binding studies","volume":"294","author":"Sankarganesh","year":"2019","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.biopha.2024.116211_bib173","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/ijms22041653","article-title":"The anticancer effect of natural plant alkaloid isoquinolines","volume":"22","author":"Yun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib174","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejmech.2018.11.047","article-title":"In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands","volume":"163","author":"Khan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib175","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1021\/acs.inorgchem.0c00423","article-title":"Antitumor and antiangiogenic properties of gold(III) complexes containing cycloaurated triphenylphosphine sulfide ligands","volume":"59","author":"Srinivasa Reddy","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib176","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfab039","article-title":"Dinuclear orthometallated gold(I)-gold(III) anticancer complexes with potent in vivo activity through an ROS-dependent mechanism","volume":"13","author":"Mirzadeh","year":"2021","journal-title":"Metallomics"},{"key":"10.1016\/j.biopha.2024.116211_bib177","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1039\/D1SC01418H","article-title":"Anticancer gold( <scp>iii<\/scp>)-bisphosphine complex alters the mitochondrial electron transport chain to induce in vivo tumor inhibition","volume":"12","author":"Kim","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib178","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1039\/D2CC03081K","article-title":"Chiral gold( <scp>iii<\/scp>) complexes: speciation, in vitro, and in vivo anticancer profile","volume":"58","author":"Arojojoye","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biopha.2024.116211_bib179","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3390\/cells8121598","article-title":"Genetic disorders associated with metal metabolism","volume":"8","author":"Umair","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116211_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron metabolism in ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2024.116211_bib181","author":"Royer","year":"2023","journal-title":"Copp. Toxic."},{"key":"10.1016\/j.biopha.2024.116211_bib182","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.fsi.2020.03.018","article-title":"Toxic effect of chronic waterborne copper exposure on growth, immunity, anti-oxidative capacity and gut microbiota of Pacific white shrimp Litopenaeus vannamei","volume":"100","author":"Qian","year":"2020","journal-title":"Fish. Shellfish Immunol."},{"key":"10.1016\/j.biopha.2024.116211_bib183","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00775-021-01866-8","article-title":"Allicin ameliorates aluminium- and copper-induced cognitive dysfunction in Wistar rats: relevance to neuro-inflammation, neurotransmitters and A\u03b2(1\u201342) analysis","volume":"26","author":"Kaur","year":"2021","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib184","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/coatings9040257","article-title":"Kinetically deposited copper antimicrobial surfaces","volume":"9","author":"Champagne","year":"2019","journal-title":"Coatings"},{"key":"10.1016\/j.biopha.2024.116211_bib185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/ph16020234","article-title":"Potential of copper and copper compounds for anticancer applications","volume":"16","author":"Ji","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2024.116211_bib186","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.drudis.2018.04.002","article-title":"The emerging role of copper-64 radiopharmaceuticals as cancer theranostics","volume":"23","author":"Boschi","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2024.116211_bib187","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-82812-1","article-title":"Copper-67 radioimmunotheranostics for simultaneous immunotherapy and immuno-SPECT","volume":"11","author":"Hao","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116211_bib188","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/ph14060549","article-title":"Targeting the copper transport system to improve treatment efficacies of platinum-containing drugs in cancer chemotherapy","volume":"14","author":"Kuo","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2024.116211_bib189","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.3390\/cancers12123594","article-title":"The multifaceted roles of copper in cancer: a trace metal element with dysregulated metabolism, but also a target or a bullet for therapy","volume":"12","author":"Leli\u00e8vre","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.116211_bib190","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib191","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ejmech.2017.04.030","article-title":"Novel mononuclear Cu (II) terpyridine complexes: Impact of fused ring thiophene and thiazole head groups towards DNA\/BSA interaction, cleavage and antiproliferative activity on HepG2 and triple negative CAL-51 cell line","volume":"135","author":"Manikandamathavan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib192","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s10870-021-00903-3","article-title":"Supramolecular Properties Directed by Weak Interactions in a Copper (II) Complex Based on 8-Hydroxy Quinoline-Pyridine Binary Ligand Systems: Crystal Structure and Hirshfeld Surface Analyses","volume":"52","author":"Bhattacharjee","year":"2022","journal-title":"J. Chem. Crystallogr."},{"key":"10.1016\/j.biopha.2024.116211_bib193","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/tcr.202000082","article-title":"8\u2010hydroxyquinoline fluorophore for sensing of metal ions and anions","volume":"20","author":"Rohini","year":"2020","journal-title":"Chem. Rec."},{"key":"10.1016\/j.biopha.2024.116211_bib194","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1039\/C4MD00284A","article-title":"8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential","volume":"6","author":"Song","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.biopha.2024.116211_bib195","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.tetlet.2006.03.044","article-title":"Fluorescence sensing of tartaric acid: a case of excimer emission caused by hydrogen bond-mediated complexation","volume":"47","author":"Ghosh","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.biopha.2024.116211_bib196","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00775-018-1596-y","article-title":"Anti-prostate cancer activity of 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide copper complexes in vivo by bioluminescence imaging","volume":"23","author":"Xie","year":"2018","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib197","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s10895-017-2133-z","article-title":"Anti-prostate cancer activity of 8-hydroxyquinoline-2-carboxaldehyde\u2013thiosemicarbazide copper complexes by fluorescent microscopic imaging","volume":"27","author":"Xie","year":"2017","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.biopha.2024.116211_bib198","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1389557043487484","article-title":"The Wide Pharmacological Versatility of Semicarbazones, Thiosemicarbazones and Their Metal Complexes","volume":"4","year":"2004","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib199","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00280-016-3200-x","article-title":"Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies","volume":"79","author":"Kunos","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib200","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1021\/ja00960a067","article-title":"The crystal structures of compounds with antitumor activity. 2-Keto-3-ethoxybutyraldehyde Bis(thiosemicarbazone) and its cupric complex 1","volume":"88","author":"Taylor","year":"1966","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2024.116211_bib201","first-page":"1278","article-title":"The antitumor activity of Cu(II)KTS, the copper (II) chelate of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone)","volume":"27","author":"Crim","year":"1967","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2024.116211_bib202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00397911.2019.1649432","article-title":"Novel thiosemicarbazone derivatives and their metal complexes: Recent development","author":"Prajapati","year":"2019","journal-title":"Synth. Commun."},{"key":"10.1016\/j.biopha.2024.116211_bib203","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.inoche.2018.06.019","article-title":"Copper complexes of new thiosemicarbazone ligands: synthesis, structural studies and antimicrobial activity","volume":"94","author":"Ibrahim","year":"2018","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.biopha.2024.116211_bib204","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bcp.2011.04.003","article-title":"Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment","volume":"82","author":"Gullbo","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib205","doi-asserted-by":"crossref","first-page":"30217","DOI":"10.18632\/oncotarget.16324","article-title":"Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity","volume":"8","author":"Karlsson","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.116211_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112266","article-title":"In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target","volume":"194","author":"Carcelli","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib207","doi-asserted-by":"crossref","first-page":"12269","DOI":"10.1016\/S0021-9258(19)86305-6","article-title":"Oxygen-dependent cleavage of DNA by the 1,10-phenanthroline. cuprous complex. Inhibition of Escherichia coli DNA polymerase I","volume":"254","author":"Sigman","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib208","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1021\/ic101791r","article-title":"Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: cytotoxicity and DNA cleavage","volume":"50","author":"Silva","year":"2011","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib209","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bbrc.2020.09.104","article-title":"In vitro and in vivo antitumoral activity of a ternary copper (II) complex","volume":"533","author":"Lopes","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2024.116211_bib210","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1021\/acs.jmedchem.0c01936","article-title":"Dithiocarbazate-copper complexes for bioimaging and treatment of pancreatic cancer","volume":"64","author":"Gou","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib211","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.inorgchem.0c00925","article-title":"Copper complexes with 1,10-phenanthroline derivatives: underlying factors affecting their cytotoxicity","volume":"59","author":"Nunes","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120463","article-title":"Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management","volume":"599","author":"Pinho","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116211_bib213","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jinorgbio.2015.09.014","article-title":"Induction of apoptosis in leukemia cell lines by new copper(II) complexes containing naphthyl groups via interaction with death receptors","volume":"153","author":"Fernandes","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111166","article-title":"In vitro and in vivo anti-proliferative activity and ultrastructure investigations of a copper(II) complex toward human lung cancer cell NCI-H460","volume":"210","author":"Maciel","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib215","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1039\/B813363H","article-title":"Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies","author":"Chen","year":"2009","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111208","article-title":"The copper(II) complexes of new anthrahydrazone ligands: In vitro and in vivo antitumor activity and structure-activity relationship","volume":"212","author":"Liu","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113182","article-title":"Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate","volume":"213","author":"Cai","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113688","article-title":"A comprehensive overview of \u03b2-carbolines and its derivatives as anticancer agents","volume":"224","author":"Luo","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib219","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0162-0134(90)85006-I","article-title":"Synthesis and characterization of novel biologically active platinum(II) and palladium(II) complexes of some \u03b2-carboline alkaloids","volume":"38","author":"Al-Allaf","year":"1990","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib220","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3390\/molecules26061606","article-title":"Bioactive tryptophan-based copper complex with auxiliary \u03b2-carboline spectacle potential on human breast cancer cells: in vitro and in vivo studies","volume":"26","author":"Alharbi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116211_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.102420","article-title":"Comparative efficacy of ternary Cu (II) complex and Zn (II)-complex in amelioration of carbon tetrachloride-induced hepatotoxicity in vivo","volume":"35","author":"Hassan","year":"2023","journal-title":"J. King Saud. Univ. - Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib222","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jinorgbio.2016.06.005","article-title":"Experimental and theoretical studies of copper complexes with isomeric dipeptides as novel candidates against breast cancer","volume":"162","author":"Facchin","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2021.115544","article-title":"Cadmium(II) coordination polymer based on flexible dithiolate-polyamine binary ligands system: Crystal structure, Hirshfeld surface analysis, antimicrobial, and DNA cleavage potential","volume":"211","author":"Bhattacharjee","year":"2022","journal-title":"Polyhedron"},{"key":"10.1016\/j.biopha.2024.116211_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135481","article-title":"Supramolecular Co(II) complexes based on dithiolate and dicarboxylate ligands: Crystal structures, theoretical studies, magnetic properties, and catalytic activity studies in photocatalytic hydrogen evolution","volume":"1285","author":"Adhikari","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.biopha.2024.116211_bib225","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1039\/D1DT00352F","article-title":"Nickel( <scp>ii<\/scp>) complexes based on dithiolate\u2013polyamine binary ligand systems: crystal structures, hirshfeld surface analysis, theoretical study, and catalytic activity study on photocatalytic hydrogen generation","volume":"50","author":"Adhikari","year":"2021","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2020.119877","article-title":"Bimetallic and trimetallic Cd(II) and Hg(II) mixed-ligand complexes with 1,1-dicyanoethylene-2,2-dithiolate and polyamines: Synthesis, crystal structure, Hirshfeld surface analysis, and antimicrobial study","volume":"512","author":"Adhikari","year":"2020","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.biopha.2024.116211_bib227","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1039\/D0CE01233E","article-title":"On the supramolecular properties of neutral, anionic and cationic cadmium complexes harvested from dithiolate\u2013polyamine binary ligand systems","volume":"22","author":"Adhikari","year":"2020","journal-title":"CrystEngComm"},{"key":"10.1016\/j.biopha.2024.116211_bib228","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.molstruc.2018.03.073","article-title":"Mixed-ligand complexes of zinc(II) with 1,1-dicyanoethylene-2,2-dithiolate and N-donor ligands: a combined experimental and theoretical study","volume":"1164","author":"Singh","year":"2018","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.biopha.2024.116211_bib229","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molstruc.2017.03.073","article-title":"A new cadmium(II) complex with bridging dithiolate ligand: Synthesis, crystal structure and antifungal activity study","volume":"1139","author":"Singh","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.biopha.2024.116211_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114859","article-title":"New NNN pincer copper complexes as potential anti-prostate cancer agents","volume":"244","author":"Qu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib231","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.molstruc.2017.08.058","article-title":"Synthesis, crystal structure and biological activity of the Schiff base organotin(IV) complexes based on salicylaldehyde-o-aminophenol","volume":"1149","author":"Tan","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.biopha.2024.116211_bib232","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.poly.2019.02.024","article-title":"Synthesis, structure and diverse coordination chemistry of cobalt(III) complexes derived from a Schiff base ligand and their biomimetic catalytic oxidation of o-aminophenols","volume":"164","author":"Jana","year":"2019","journal-title":"Polyhedron"},{"key":"10.1016\/j.biopha.2024.116211_bib233","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.3390\/molecules28124876","article-title":"Anticancer activity and mode of action of Cu(II), Zn(II), and Mn(II) complexes with 5-chloro-2-N-(2-quinolylmethylene)aminophenol","volume":"28","author":"Gai","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116211_bib234","article-title":"Current status of iridium-based complexes against lung cancer","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116211_bib235","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.3390\/molecules24152739","article-title":"Iridium(III) complexes targeting apoptotic cell death in cancer cells","volume":"24","author":"Ma","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116211_bib236","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202205429","article-title":"A biodegradable iridium(III) coordination polymer for enhanced two\u2010photon photodynamic therapy using an apoptosis\u2013ferroptosis hybrid pathway","volume":"61","author":"Ke","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.116211_bib237","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/2211-5463.13381","article-title":"Metallodrugs: an approach against invasion and metastasis in cancer treatment","volume":"12","author":"Gonz\u00e1lez\u2010Ballesteros","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.biopha.2024.116211_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2020.119925","article-title":"Advances in novel iridium (III) based complexes for anticancer applications: a review","volume":"513","author":"Sharma S","year":"2020","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.biopha.2024.116211_bib239","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12668-022-00941-x","article-title":"A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents","volume":"12","author":"Andra","year":"2022","journal-title":"Bionanoscience"},{"key":"10.1016\/j.biopha.2024.116211_bib240","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejmech.2019.06.009","article-title":"Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system","volume":"178","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111014","article-title":"Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo","volume":"205","author":"Bai","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111215","article-title":"Exploring anticancer efficiency of mitochondria-targeted cyclometalated iridium(III) complexes","volume":"212","author":"Gu","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib243","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00775-020-01841-9","article-title":"Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex","volume":"26","author":"Gu","year":"2021","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib244","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ccr.2018.01.010","article-title":"Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy","volume":"360","author":"Zamora","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib245","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1039\/C9QI01492F","article-title":"Novel cyclometalated iridium( <scp>iii<\/scp>) phosphine-imine (P^N) complexes: highly efficient anticancer and anti-lung metastasis agents in vivo","volume":"7","author":"Xu","year":"2020","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.biopha.2024.116211_bib246","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1039\/D1SC05478C","article-title":"Recent advances in noble metal complex based photodynamic therapy","volume":"13","author":"Wu","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214283","article-title":"Mitochondria targeted fluorogenic theranostic agents for cancer therapy","volume":"452","author":"Singh","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.biopha.2024.116211_bib248","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.1039\/C8DT00783G","article-title":"Cyclometalated iridium( <scp>iii<\/scp>) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo","volume":"47","author":"He","year":"2018","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib249","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1002\/anie.202015671","article-title":"In\u2010vitro and in\u2010vivo photocatalytic cancer therapy with biocompatible iridium(III) photocatalysts","volume":"60","author":"Huang","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.116211_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105290","article-title":"Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria","volume":"115","author":"Zhang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib251","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejmech.2017.11.091","article-title":"Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex","volume":"145","author":"Yi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib252","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejmech.2019.06.003","article-title":"Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells","volume":"178","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib253","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/acsmedchemlett.9b00337","article-title":"Novel quinoline-based Ir(III) complexes exhibit high antitumor activity in vitro and in vivo","volume":"10","author":"Yang","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2024.116211_bib254","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1039\/D1QI01542G","article-title":"Polyurethane\u2013polyurea hybrid nanocapsules as efficient delivery systems of anticancer Ir( <scp>iii<\/scp>) metallodrugs","volume":"9","author":"Bonelli","year":"2022","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.biopha.2024.116211_bib255","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04526-5","article-title":"Potent anticancer activity of a novel iridium metallodrug via oncosis","volume":"79","author":"Ortega-Forte","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib256","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106867","article-title":"Iridium(III) complex induces apoptosis in HeLa cells by regulating mitochondrial and PI3K\/AKT signaling pathways: In vitro and in vivo experiments","volume":"141","author":"He","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib257","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/08982104.2020.1818779","article-title":"Liposome as drug delivery system enhance anticancer activity of iridium (III) complex","volume":"31","author":"Gu","year":"2021","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biopha.2024.116211_bib258","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1039\/D0SC03563G","article-title":"Triazole-based osmium( <scp>ii<\/scp>) complexes displaying red\/near-IR luminescence: antimicrobial activity and super-resolution imaging","volume":"11","author":"Smitten","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib259","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfab007","article-title":"Osmium\u2013arene complexes with high potency towards Mycobacterium tuberculosis","volume":"13","author":"Coverdale","year":"2021","journal-title":"Metallomics"},{"key":"10.1016\/j.biopha.2024.116211_bib260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112483","article-title":"Synthesis, structure and anti-cancer activity of osmium complexes bearing \u03c0-bound arene substituents and phosphane Co-Ligands: a review","volume":"201","author":"Nabiyeva","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116211_bib261","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-03-0746","article-title":"A phase I and pharmacological study with imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel ruthenium anticancer Agent","volume":"10","author":"Rademaker-Lakhai","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2024.116211_bib262","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jinorgbio.2006.02.013","article-title":"From bench to bedside \u2013 preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)","volume":"100","author":"Hartinger","year":"2006","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2024.116211_bib263","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.canlet.2017.11.041","article-title":"Anticancer activity of osmium(VI) nitrido complexes in patient-derived glioblastoma initiating cells and in vivo mouse models","volume":"416","author":"Berger","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.116211_bib264","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1039\/C9QI01148J","article-title":"Anticancer activity of ruthenium and osmium cyclometalated compounds: identification of ABCB1 and EGFR as resistance mechanisms","volume":"7","author":"Licona","year":"2020","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.biopha.2024.116211_bib265","doi-asserted-by":"crossref","first-page":"17173","DOI":"10.1039\/D0DT02715D","article-title":"A cytotoxic nitrido-osmium( <scp>vi<\/scp>) complex induces caspase-mediated apoptosis in HepG2 cancer cells","volume":"49","author":"Huang","year":"2020","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib266","doi-asserted-by":"crossref","first-page":"10553","DOI":"10.1039\/c1dt10937e","article-title":"Structure\u2013activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity","volume":"40","author":"Fu","year":"2011","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.biopha.2024.116211_bib267","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1039\/c1md00075f","article-title":"Anti-colorectal cancer activity of an organometallic osmium arene azopyridine complex","volume":"2","author":"Shnyder","year":"2011","journal-title":"Medchemcomm"},{"key":"10.1016\/j.biopha.2024.116211_bib268","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1500925112","article-title":"Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells","volume":"112","author":"Hearn","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib269","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfaa003","article-title":"Dose- and time-dependent tolerability and efficacy of organo-osmium complex FY26 and its tissue pharmacokinetics in hepatocarcinoma-bearing mice","volume":"13","author":"Kumar","year":"2021","journal-title":"Metallomics"},{"key":"10.1016\/j.biopha.2024.116211_bib270","doi-asserted-by":"crossref","DOI":"10.1007\/s12039-019-1646-1","article-title":"Recent developments in synthetic chemistry and biological activities of pyrazole derivatives","volume":"131","author":"Faisal","year":"2019","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib271","doi-asserted-by":"crossref","first-page":"12779","DOI":"10.3390\/ijms232112779","article-title":"A pyrazolate osmium(VI) nitride exhibits anticancer activity through modulating protein homeostasis in HepG2 Cells","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116211_bib272","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202218347","article-title":"Structurally simple osmium(II) polypyridyl complexes as photosensitizers for photodynamic therapy in the near infrared**","volume":"62","author":"Mani","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.116211_bib273","article-title":"The gold complex auranofin: new perspectives for cancer therapy","volume":"12","author":"Abdalbari","year":"2021","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.biopha.2024.116211_bib274","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/CAD.0000000000000009","article-title":"Phase I dose escalation study of the PKC\u03b9 inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer","volume":"24","author":"Mansfield","year":"2013","journal-title":"Anticancer. Drugs"},{"key":"10.1016\/j.biopha.2024.116211_bib275","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2018.10.001","article-title":"A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology\/gynecologic oncology group study","volume":"151","author":"Monk","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2024.116211_bib276","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tiv.2016.02.008","article-title":"Effect of [Cu(4,7-dimethyl-1,10-phenanthroline)(acetylacetonato)]NO3, Casiope\u00edna III-Ea, on the activity of cytochrome P450","volume":"33","author":"Campero-Peredo","year":"2016","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.biopha.2024.116211_bib277","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.3390\/molecules27196485","article-title":"Metallo-drugs in cancer therapy: past, present and future","volume":"27","author":"Lucaciu","year":"2022","journal-title":"Molecules"}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119407","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000}},{"DOI":"10.1016\/j.biopha.2024.116211","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000}},{"DOI":"10.1016\/j.biopha.2026.119407","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224000921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224000921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:52:49Z","timestamp":1792097569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224000921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":277,"alternative-id":["S0753332224000921"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116211","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116211"}}